Plasma orexin-A levels in patients with obstructive sleep apnea syndrome

K. Aksu, S. Firat Guven, B. Ciftci, T. Ulukavak Ciftci, S. Aksaray, F. Aksu, T. Sipit (Ankara, Turkey)

Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Session: Metabolic consequences of obstructive sleep apnoea
Session type: Electronic Poster Discussion
Number: 4097
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Aksu, S. Firat Guven, B. Ciftci, T. Ulukavak Ciftci, S. Aksaray, F. Aksu, T. Sipit (Ankara, Turkey). Plasma orexin-A levels in patients with obstructive sleep apnea syndrome. Eur Respir J 2007; 30: Suppl. 51, 4097

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Leptin and ghrelin levels in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 332s
Year: 2004

Serum leptin levels in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007


Serum leptin levels in obese patients with severe obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 332s
Year: 2004

Investigation on serum adiponectin levels in patients with obstructive sleep apnea hypopnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 445s
Year: 2004

Plasma adiponectin levels and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2004 - Systemic and metabolic effects from OSA
Year: 2004


Elevated serum homocysteine levels in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 566s
Year: 2004

Serum fibrinogen in patients with obstructive sleep apnea
Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Year: 2020

Plasma levels of TNF in obstructive sleep apnea syndrome (OSA) before and after surgical intervention
Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology
Year: 2012


Angio-inhibitory activity and decreased leptin level in sera from obstructive sleep apnea syndrome (OSAS) patients
Source: Eur Respir J 2001; 18: Suppl. 33, 334s
Year: 2001

Serum resistin level in pediatric obstructive sleep apnea
Source: Annual Congress 2008 - Paediatric respiratory epidemiology I: primary ciliary dyskinesia, sleep-disordered breathing, exercise-induced symptoms and rare diseases
Year: 2008

Circulating survivin levels in patients with obstructive sleep apnea
Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers
Year: 2017

Serum omentin levels in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2013 –Sleep disordered breathing in special situations I
Year: 2013


C-reactive protein levels in obstructive sleep apnea syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 356s
Year: 2005

Plasma homocysteine (Hcy) levels in patients with obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2007 - Cardiovascular and respiratory control in obstructive sleep apnoea
Year: 2007


Peculiarities of GABA levels in plasma and urine of asthma patients with obstructive sleep apnea
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020


Visfatin levels in sleep apnea syndrome
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007


The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 113s
Year: 2004

Relationship between NT-proBNP plasma level and nocturia in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea
Year: 2007


Elevated c-reactive protein in patients with obstructive sleep apnea hypopnea syndrome (OSAH)
Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea
Year: 2007


Metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007